Airsonett is a research-based medical technology company that develops non-pharmaceutical treatment for allergic asthma.
Airsonett has raised $2.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2022.
Airsonett's investors include Industrifonden, Fåhraeus Startup and Growth, SEB Venture Capital.
Airsonett is headquartered in Ängelholm, Sweden.
Airsonett is a research-based medical technology company that develops non-pharmaceutical treatment for allergic asthma.
Airsonett is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Airsonett — Funding & Investors." VCBacked, July 30, 2022, https://www.vcbacked.co/company/airsonett. Accessed September 30, 2026.
VCBacked. (2022). Airsonett — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/airsonett
{{cite web |title=Airsonett — Funding & Investors |url=https://www.vcbacked.co/company/airsonett |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated